Identification of POU4F1 as a novel prognostic biomarker and therapeutic target in esophageal squamous cell carcinoma
POU4F1 is a novel and promising prognostic and therapeutic target for ESCC patients, providing insights into potential treatment strategies.
Authors
- Shaoxiang Wang (ORCID: https://orcid.org/0000-0001-7653-4883)
- Boqing Zhang (ORCID: https://orcid.org/0000-0002-1507-6556)
- Kai Zheng (ORCID: https://orcid.org/0000-0001-9122-877X)
- Nan Li (ORCID: https://orcid.org/0000-0001-7808-5161)
- Xiao Wang (ORCID: https://orcid.org/0000-0001-8824-6280)
- Siying Chen (ORCID: https://orcid.org/0000-0002-2708-6559)
- Chao Sun (ORCID: https://orcid.org/0000-0002-8055-1640)
- Qiuling Chen (ORCID: https://orcid.org/0000-0003-0565-8082)
Institutions
- Jinan University (CN)
- China Pharmaceutical University (CN)
- Shenzhen University (CN)
- Southern University of Science and Technology (CN)
- Shantou University (CN)
- Cancer Hospital of Shantou University Medical College (CN)
- Shenzhen University Health Science Center (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1186/s12935-024-03471-6
- Citations
- 7
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province